Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 51,544 |
|
|||||
| News | - | ||||||
| Day High | 0.63 | Low High |
|||||
| Day Low | 0.60 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| BioNexus Gene Lab Corporation | BGLC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0188 | -3.03% | 0.6011 | 15:14:47 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.60 | 0.60 | 0.63 | 0.6144 | 0.6199 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 120 | 51,544 | US$ 0.6092432 | US$ 31,403 | - | 0.31 - 9.49 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:14:47 | formt | 665 | US$ 0.6011 | USD |
BioNexus Gene Lab Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.78M | 17.67M | - | 10.26M | -2.63M | -0.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioNexus Gene Lab News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/18/2024 | 13:52 | GlobeNewswire Inc. | BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in.. |
| 1/26/2024 | 15:05 | Edgar (US Regulatory) | Form PRE 14C - Other preliminary information statements |
| 1/23/2024 | 06:55 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 11/03/2023 | 09:55 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/07/2023 | 10:17 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/24/2023 | 16:28 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/24/2023 | 10:30 | GlobeNewswire Inc. | BioNexus Gene Lab Corp. Announces Closing of $5.75 Million.. |
| 7/20/2023 | 12:29 | GlobeNewswire Inc. | BioNexus Gene Lab Corp. Announces Pricing of $5 Million.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BGLC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.645 | 0.645 | 0.582 | 0.6021331 | 55,155 | -0.0439 | -6.81% |
| 1 Month | 0.6352 | 1.00 | 0.58 | 0.747043 | 278,586 | -0.0341 | -5.37% |
| 3 Months | 0.435 | 3.39 | 0.4004 | 1.42 | 1,660,531 | 0.1661 | 38.18% |
| 6 Months | 0.3975 | 3.39 | 0.31 | 1.13 | 1,807,700 | 0.2036 | 51.22% |
| 1 Year | 3.50 | 9.49 | 0.31 | 1.50 | 2,043,342 | -2.90 | -82.83% |
| 3 Years | 3.50 | 9.49 | 0.31 | 1.50 | 2,043,342 | -2.90 | -82.83% |
| 5 Years | 3.50 | 9.49 | 0.31 | 1.50 | 2,043,342 | -2.90 | -82.83% |
BioNexus Gene Lab Description
| BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis. |
